News | June 16, 2022
Glenmark becomes the first company to launch Indacaterol + Mometasone FDC for asthma in India
Glenmark is the first company in India to market the innovative FDC of Indacaterol
Glenmark is the first company in India to market the innovative FDC of Indacaterol
Dr. Reddy's Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
Tislelizumab is now approved in nine indications in China
Centre of Excellence at Kharel comprises Skill-building Centre and Primary, Secondary and Higher Secondary schools
Plans to establish six state of the art TaCa Centre for Surgery in next 2 years in these states
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Bempedoic acid helps lower cardiovascular risk in high or very high-risk atherosclerotic cardiovascular disease (ASCVD) patients as an add-on therapy to maximally tolerated statin and/or ezetimibe
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
Subscribe To Our Newsletter & Stay Updated
